Long Non-Coding RNA CDKN2B-AS1 Facilitates Laryngeal Squamous Cell Cancer Through Regulating miR-497/CDK6 Pathway
Identifieur interne : 000C35 ( Ncbi/Merge ); précédent : 000C34; suivant : 000C36Long Non-Coding RNA CDKN2B-AS1 Facilitates Laryngeal Squamous Cell Cancer Through Regulating miR-497/CDK6 Pathway
Auteurs : Xiangyan Cui [République populaire de Chine] ; Tingting Yu [République populaire de Chine] ; Jing Shang [République populaire de Chine] ; Dong Xiao [République populaire de Chine] ; Xin Wang [République populaire de Chine]Source :
- OncoTargets and therapy [ 1178-6930 ] ; 2019.
Abstract
CDKN2B antisense RNA 1 (CDKN2B-AS1), a long noncoding RNA, was reported to play crucial roles in the progression of multiple cancers. However, the functional roles and regulatory mechanism of CDKN2B-AS1 in human laryngeal squamous cell cancer (LSCC) remain unclear. The goals of this study were to investigate biological roles and underlying mechanisms of CDKN2B-AS1 in LSCC.
The expressions of CDKN2B-AS1, miR-497 and cyclin-dependent kinase 6 (CDK6) were detected in LSCC tissues and cell lines by real-time quantitative PCR (qRT-PCR). The effects of CDKN2B-AS1 on LSCC cell proliferation, apoptosis, migration and invasion were examined by corresponding experiments. Bioinformatics analysis and luciferase activity assay were applied to analyze the interaction between CDKN2B-AS1 and miR-497.
The expression of CDKN2B-AS1 was significantly higher in LSCC tissues than in adjacent normal tissues. Higher CDKN2B-AS1 was closely associated with lymph node metastasis and advanced clinical stage. Moreover, CDKN2B-AS1 knockdown by siRNA significantly inhibited the proliferation, induced cell apoptosis, and suppressed migration and invasion in LSCC cells. Mechanically, CDKN2B functions as an oncogenic lncRNA in LSCC via regulating miR-497/CDK6 axis.
The observations in this study identify CDKN2B-AS1 an oncogenic role in the tumorigenesis of LSCC by regulating miR-497/CDK6 axis and indicate that it may serve as a potential target for LSCC treatment.
Url:
DOI: 10.2147/OTT.S221620
PubMed: 31754305
PubMed Central: 6825505
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: 000740
- to stream Pmc, to step Curation: 000740
- to stream Pmc, to step Checkpoint: 000633
Links to Exploration step
PMC:6825505Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Long Non-Coding RNA CDKN2B-AS1 Facilitates Laryngeal Squamous Cell Cancer Through Regulating miR-497/CDK6 Pathway</title>
<author><name sortKey="Cui, Xiangyan" sort="Cui, Xiangyan" uniqKey="Cui X" first="Xiangyan" last="Cui">Xiangyan Cui</name>
<affiliation wicri:level="1"><nlm:aff id="AFF0001"><institution>Department of Otolaryngology-Head and Neck Surgery, The First Hospital of Jilin University</institution>
,<addr-line>Changchun</addr-line>
<addr-line>130021</addr-line>
,<country>People’s Republic of China</country>
</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Yu, Tingting" sort="Yu, Tingting" uniqKey="Yu T" first="Tingting" last="Yu">Tingting Yu</name>
<affiliation wicri:level="1"><nlm:aff id="AFF0001"><institution>Department of Otolaryngology-Head and Neck Surgery, The First Hospital of Jilin University</institution>
,<addr-line>Changchun</addr-line>
<addr-line>130021</addr-line>
,<country>People’s Republic of China</country>
</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Shang, Jing" sort="Shang, Jing" uniqKey="Shang J" first="Jing" last="Shang">Jing Shang</name>
<affiliation wicri:level="1"><nlm:aff id="AFF0001"><institution>Department of Otolaryngology-Head and Neck Surgery, The First Hospital of Jilin University</institution>
,<addr-line>Changchun</addr-line>
<addr-line>130021</addr-line>
,<country>People’s Republic of China</country>
</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Xiao, Dong" sort="Xiao, Dong" uniqKey="Xiao D" first="Dong" last="Xiao">Dong Xiao</name>
<affiliation wicri:level="1"><nlm:aff id="AFF0001"><institution>Department of Otolaryngology-Head and Neck Surgery, The First Hospital of Jilin University</institution>
,<addr-line>Changchun</addr-line>
<addr-line>130021</addr-line>
,<country>People’s Republic of China</country>
</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Wang, Xin" sort="Wang, Xin" uniqKey="Wang X" first="Xin" last="Wang">Xin Wang</name>
<affiliation wicri:level="1"><nlm:aff id="AFF0001"><institution>Department of Otolaryngology-Head and Neck Surgery, The First Hospital of Jilin University</institution>
,<addr-line>Changchun</addr-line>
<addr-line>130021</addr-line>
,<country>People’s Republic of China</country>
</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">31754305</idno>
<idno type="pmc">6825505</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825505</idno>
<idno type="RBID">PMC:6825505</idno>
<idno type="doi">10.2147/OTT.S221620</idno>
<date when="2019">2019</date>
<idno type="wicri:Area/Pmc/Corpus">000740</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000740</idno>
<idno type="wicri:Area/Pmc/Curation">000740</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000740</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000633</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000633</idno>
<idno type="wicri:Area/Ncbi/Merge">000C35</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Long Non-Coding RNA CDKN2B-AS1 Facilitates Laryngeal Squamous Cell Cancer Through Regulating miR-497/CDK6 Pathway</title>
<author><name sortKey="Cui, Xiangyan" sort="Cui, Xiangyan" uniqKey="Cui X" first="Xiangyan" last="Cui">Xiangyan Cui</name>
<affiliation wicri:level="1"><nlm:aff id="AFF0001"><institution>Department of Otolaryngology-Head and Neck Surgery, The First Hospital of Jilin University</institution>
,<addr-line>Changchun</addr-line>
<addr-line>130021</addr-line>
,<country>People’s Republic of China</country>
</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Yu, Tingting" sort="Yu, Tingting" uniqKey="Yu T" first="Tingting" last="Yu">Tingting Yu</name>
<affiliation wicri:level="1"><nlm:aff id="AFF0001"><institution>Department of Otolaryngology-Head and Neck Surgery, The First Hospital of Jilin University</institution>
,<addr-line>Changchun</addr-line>
<addr-line>130021</addr-line>
,<country>People’s Republic of China</country>
</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Shang, Jing" sort="Shang, Jing" uniqKey="Shang J" first="Jing" last="Shang">Jing Shang</name>
<affiliation wicri:level="1"><nlm:aff id="AFF0001"><institution>Department of Otolaryngology-Head and Neck Surgery, The First Hospital of Jilin University</institution>
,<addr-line>Changchun</addr-line>
<addr-line>130021</addr-line>
,<country>People’s Republic of China</country>
</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Xiao, Dong" sort="Xiao, Dong" uniqKey="Xiao D" first="Dong" last="Xiao">Dong Xiao</name>
<affiliation wicri:level="1"><nlm:aff id="AFF0001"><institution>Department of Otolaryngology-Head and Neck Surgery, The First Hospital of Jilin University</institution>
,<addr-line>Changchun</addr-line>
<addr-line>130021</addr-line>
,<country>People’s Republic of China</country>
</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Wang, Xin" sort="Wang, Xin" uniqKey="Wang X" first="Xin" last="Wang">Xin Wang</name>
<affiliation wicri:level="1"><nlm:aff id="AFF0001"><institution>Department of Otolaryngology-Head and Neck Surgery, The First Hospital of Jilin University</institution>
,<addr-line>Changchun</addr-line>
<addr-line>130021</addr-line>
,<country>People’s Republic of China</country>
</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series><title level="j">OncoTargets and therapy</title>
<idno type="eISSN">1178-6930</idno>
<imprint><date when="2019">2019</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><sec id="S2001"><title>Background</title>
<p>CDKN2B antisense RNA 1 (CDKN2B-AS1), a long noncoding RNA, was reported to play crucial roles in the progression of multiple cancers. However, the functional roles and regulatory mechanism of CDKN2B-AS1 in human laryngeal squamous cell cancer (LSCC) remain unclear. The goals of this study were to investigate biological roles and underlying mechanisms of CDKN2B-AS1 in LSCC.</p>
</sec>
<sec id="S2002"><title>Methods</title>
<p>The expressions of CDKN2B-AS1, miR-497 and cyclin-dependent kinase 6 (CDK6) were detected in LSCC tissues and cell lines by real-time quantitative PCR (qRT-PCR). The effects of CDKN2B-AS1 on LSCC cell proliferation, apoptosis, migration and invasion were examined by corresponding experiments. Bioinformatics analysis and luciferase activity assay were applied to analyze the interaction between CDKN2B-AS1 and miR-497.</p>
</sec>
<sec id="S2003"><title>Results</title>
<p>The expression of CDKN2B-AS1 was significantly higher in LSCC tissues than in adjacent normal tissues. Higher CDKN2B-AS1 was closely associated with lymph node metastasis and advanced clinical stage. Moreover, CDKN2B-AS1 knockdown by siRNA significantly inhibited the proliferation, induced cell apoptosis, and suppressed migration and invasion in LSCC cells. Mechanically, CDKN2B functions as an oncogenic lncRNA in LSCC via regulating miR-497/CDK6 axis.</p>
</sec>
<sec id="S2004"><title>Conclusion</title>
<p>The observations in this study identify CDKN2B-AS1 an oncogenic role in the tumorigenesis of LSCC by regulating miR-497/CDK6 axis and indicate that it may serve as a potential target for LSCC treatment.</p>
</sec>
</div>
</front>
<back><div1 type="bibliography"><listBibl><biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
</listBibl>
</div1>
</back>
</TEI>
<pmc article-type="research-article"><pmc-dir>properties open_access</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-ta">Onco Targets Ther</journal-id>
<journal-id journal-id-type="iso-abbrev">Onco Targets Ther</journal-id>
<journal-id journal-id-type="publisher-id">OTT</journal-id>
<journal-id journal-id-type="pmc">ott</journal-id>
<journal-title-group><journal-title>OncoTargets and therapy</journal-title>
</journal-title-group>
<issn pub-type="epub">1178-6930</issn>
<publisher><publisher-name>Dove</publisher-name>
</publisher>
</journal-meta>
<article-meta><article-id pub-id-type="pmid">31754305</article-id>
<article-id pub-id-type="pmc">6825505</article-id>
<article-id pub-id-type="publisher-id">221620</article-id>
<article-id pub-id-type="doi">10.2147/OTT.S221620</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Original Research</subject>
</subj-group>
</article-categories>
<title-group><article-title>Long Non-Coding RNA CDKN2B-AS1 Facilitates Laryngeal Squamous Cell Cancer Through Regulating miR-497/CDK6 Pathway</article-title>
<alt-title alt-title-type="running-authors">Cui et al</alt-title>
<alt-title alt-title-type="running-title">Cui et al</alt-title>
</title-group>
<contrib-group><contrib contrib-type="author"><name><surname>Cui</surname>
<given-names>Xiangyan</given-names>
</name>
<xref ref-type="aff" rid="AFF0001">1</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Yu</surname>
<given-names>Tingting</given-names>
</name>
<xref ref-type="aff" rid="AFF0001">1</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Shang</surname>
<given-names>Jing</given-names>
</name>
<xref ref-type="aff" rid="AFF0001">1</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Xiao</surname>
<given-names>Dong</given-names>
</name>
<xref ref-type="aff" rid="AFF0001">1</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Wang</surname>
<given-names>Xin</given-names>
</name>
<xref ref-type="corresp" rid="AN0001"></xref>
<xref ref-type="aff" rid="AFF0001">1</xref>
</contrib>
<aff id="AFF0001"><label>1</label>
<institution>Department of Otolaryngology-Head and Neck Surgery, The First Hospital of Jilin University</institution>
,<addr-line>Changchun</addr-line>
<addr-line>130021</addr-line>
,<country>People’s Republic of China</country>
</aff>
</contrib-group>
<author-notes><corresp id="AN0001">Correspondence: Xin Wang <institution>Department of Otolaryngology-Head and Neck Surgery, The First Hospital of Jilin University</institution>
, <addr-line>No. 71 Xinmin Street</addr-line>
, <addr-line>Changchun</addr-line>
<addr-line>130021</addr-line>
, <country>People’s Republic of China</country>
Email wangxinjdyy@126.com</corresp>
</author-notes>
<pub-date pub-type="epub"><day>29</day>
<month>10</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection"><year>2019</year>
</pub-date>
<volume>12</volume>
<fpage>8853</fpage>
<lpage>8862</lpage>
<history><date date-type="received"><day>02</day>
<month>7</month>
<year>2019</year>
</date>
<date date-type="accepted"><day>24</day>
<month>9</month>
<year>2019</year>
</date>
</history>
<permissions><copyright-statement>© 2019 Cui et al.</copyright-statement>
<copyright-year>2019</copyright-year>
<copyright-holder>Cui et al.</copyright-holder>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/"><license-p>This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at <ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link>
and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>
). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (<ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link>
).</license-p>
</license>
</permissions>
<abstract><sec id="S2001"><title>Background</title>
<p>CDKN2B antisense RNA 1 (CDKN2B-AS1), a long noncoding RNA, was reported to play crucial roles in the progression of multiple cancers. However, the functional roles and regulatory mechanism of CDKN2B-AS1 in human laryngeal squamous cell cancer (LSCC) remain unclear. The goals of this study were to investigate biological roles and underlying mechanisms of CDKN2B-AS1 in LSCC.</p>
</sec>
<sec id="S2002"><title>Methods</title>
<p>The expressions of CDKN2B-AS1, miR-497 and cyclin-dependent kinase 6 (CDK6) were detected in LSCC tissues and cell lines by real-time quantitative PCR (qRT-PCR). The effects of CDKN2B-AS1 on LSCC cell proliferation, apoptosis, migration and invasion were examined by corresponding experiments. Bioinformatics analysis and luciferase activity assay were applied to analyze the interaction between CDKN2B-AS1 and miR-497.</p>
</sec>
<sec id="S2003"><title>Results</title>
<p>The expression of CDKN2B-AS1 was significantly higher in LSCC tissues than in adjacent normal tissues. Higher CDKN2B-AS1 was closely associated with lymph node metastasis and advanced clinical stage. Moreover, CDKN2B-AS1 knockdown by siRNA significantly inhibited the proliferation, induced cell apoptosis, and suppressed migration and invasion in LSCC cells. Mechanically, CDKN2B functions as an oncogenic lncRNA in LSCC via regulating miR-497/CDK6 axis.</p>
</sec>
<sec id="S2004"><title>Conclusion</title>
<p>The observations in this study identify CDKN2B-AS1 an oncogenic role in the tumorigenesis of LSCC by regulating miR-497/CDK6 axis and indicate that it may serve as a potential target for LSCC treatment.</p>
</sec>
</abstract>
<kwd-group kwd-group-type="author"><title>Keywords</title>
<kwd>laryngeal squamous cell cancer</kwd>
<kwd>long noncoding RNA</kwd>
<kwd>CDKN2B-AS1</kwd>
<kwd>CDK6</kwd>
<kwd>miR-497</kwd>
</kwd-group>
<counts><fig-count count="5"></fig-count>
<table-count count="1"></table-count>
<ref-count count="33"></ref-count>
<page-count count="10"></page-count>
</counts>
</article-meta>
</front>
</pmc>
<affiliations><list><country><li>République populaire de Chine</li>
</country>
</list>
<tree><country name="République populaire de Chine"><noRegion><name sortKey="Cui, Xiangyan" sort="Cui, Xiangyan" uniqKey="Cui X" first="Xiangyan" last="Cui">Xiangyan Cui</name>
</noRegion>
<name sortKey="Shang, Jing" sort="Shang, Jing" uniqKey="Shang J" first="Jing" last="Shang">Jing Shang</name>
<name sortKey="Wang, Xin" sort="Wang, Xin" uniqKey="Wang X" first="Xin" last="Wang">Xin Wang</name>
<name sortKey="Xiao, Dong" sort="Xiao, Dong" uniqKey="Xiao D" first="Dong" last="Xiao">Dong Xiao</name>
<name sortKey="Yu, Tingting" sort="Yu, Tingting" uniqKey="Yu T" first="Tingting" last="Yu">Tingting Yu</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000C35 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 000C35 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= ChloroquineV1 |flux= Ncbi |étape= Merge |type= RBID |clé= PMC:6825505 |texte= Long Non-Coding RNA CDKN2B-AS1 Facilitates Laryngeal Squamous Cell Cancer Through Regulating miR-497/CDK6 Pathway }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:31754305" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \ | NlmPubMed2Wicri -a ChloroquineV1
![]() | This area was generated with Dilib version V0.6.33. | ![]() |